Metimmox Success Featured in the News
The Metimmox trial, which has been running at Norwegian hospitals (Akershus University Hospital, St. Olav’s University Hospital, Haukeland University Hospital,
Read more
Research
The Value of Anti-Angiogenic Treatments in PMP
There is a lot of evidence to suggest anti-angiogenic treatment (treatments that stop new blood vessels from growing) might be
Read more
New Marker for Risk of Liver Metastasis from Rectal Cancer Identified
A group of Acredit members, led by Dr Sebastian Meltzer has published a new paper outlining that the higher the
Read more
EV Phenotype Impact and Function of Monocytes in CRC
New research looking at the impact of tumor-derived extracellular vesicles (EVs) on the phenotype and function of monocytes has been
Read more
Rectal Tumour Blood Flow May Predict CT Response
New research looking at the differences in tumour blood flow between patients of different sexes has been published by Acredit’s
Read more
Review: Tumour Immunogenicity in CRC
CMOR members Erta Kalanxi, Sebastian Meltzer and Anne Hansen Ree have published a new review article looking into the current
Read more
Incidence and Prevalence Rate of PMP in Europe Estimated
Acredit members Thale Dawn Patrick-Brown and Kjersti Flatmark have published a new paper on the prevalence and incidence of pseudomyxoma
Read more
New Paper Looks into Patient-Derived Xenograft Models
Acredit’s Karianne Giller Fleten has published a paper entitled “Experimental treatment of mucinous peritoneal metastases using patient-derived xenograft models”. In
Read more
New paper highlights value of circulating FLT3LG in immunogenic response to chemotherapy
An Editorial written by the Kroemer group from the Gustave Roussy Comprehensive Cancer Institute highlights the recent research by Anne
Read more
Molecularly Matched Therapy and Outcomes in End-Stage Cancers
Lead Acredit professors Anne Hansen Ree and Kjersti Flatmark have published a paper outlining the final results from the MetAction
Read more